Niagen Bioscience (NAGE) News Today $10.16 -0.19 (-1.84%) As of 07/18/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAGE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Average PT from AnalystsJuly 19 at 2:59 AM | americanbankingnews.comNiagen Bioscience (NASDAQ:NAGE) Shares Down 4% - Here's What HappenedJuly 18 at 6:38 PM | marketbeat.comNiagen Bioscience Inc. (NAGE) Stock Price Today - WSJJuly 18 at 9:45 AM | wsj.comRobert Fried Says Niagen Bioscience Has the Key to Better Aging, and He Has the Science to Prove ItJuly 16, 2025 | latimes.comNiagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Recommendation of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comNiagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New YorkJuly 14, 2025 | theglobeandmail.comNiagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New YorkJuly 14, 2025 | businesswire.comNiagen Bioscience stock rises on exclusive Parkinson’s treatment licenseJuly 9, 2025 | in.investing.comNiagen Bioscience Shares Climb Following Exclusive License for Parkinson’s TherapyJuly 9, 2025 | msn.comNiagen Bioscience Secures Exclusive License to Develop and Commercialize its NAD+ Precursor, Patented Nicotinamide Riboside (Niagen®), as a Potential Parkinson's Disease Therapy in Agreement with Haukeland University Hospital in Bergen, NorwayJuly 8, 2025 | businesswire.comNAGE - Niagen Bioscience Inc Executives - MorningstarJuly 1, 2025 | morningstar.comMNiagen Bioscience (NASDAQ:NAGE) Stock Price Down 9.5% - Here's What HappenedJuly 1, 2025 | marketbeat.comEarnings Forecast & History for Niagen Bioscience Inc (NAGE) | Price ReactionsJuly 1, 2025 | investing.comNiagen Bioscience (NASDAQ:NAGE) Reaches New 1-Year High - What's Next?June 30, 2025 | marketbeat.com2NAGE : Breaking Update: Wendy Tak Wing YU Engages In Options Exercise At Niagen...June 27, 2025 | benzinga.com1NAGE : Engaging In Insider Activity, Kristin Patrick At Niagen Bioscience Exercises...June 27, 2025 | benzinga.comMajor Update: Frank Jaksch Jr At Niagen Bioscience Exercises Options, Realizing $0June 26, 2025 | benzinga.comOptions Exercise Update At Niagen Bioscience: Ann Cohen Engages, Resulting In $0June 26, 2025 | benzinga.comSteven Rubin At Niagen Bioscience Exercises Options Worth $0June 26, 2025 | benzinga.comNiagen Bioscience, Inc. (NAGE) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comNiagen Biosciences: Anti-Aging Market Leader And Prime Beneficiary Of Long-Term Demographic TrendsJune 24, 2025 | seekingalpha.comEven though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 yearsJune 23, 2025 | finance.yahoo.comNiagen Bioscience (NASDAQ:NAGE) Raised to Strong-Buy at Wall Street ZenJune 22, 2025 | marketbeat.comNiagen Bioscience, Inc: Niagen Bioscience to Participate at the Roth 15th Annual London ConferenceJune 20, 2025 | finanznachrichten.deNiagen Bioscience to Participate at the Roth 15th Annual London ConferenceJune 20, 2025 | businesswire.comNiagen Bioscience (NASDAQ:NAGE) Shares Down 2.4% - Should You Sell?June 18, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Downgraded to Buy Rating by Wall Street ZenJune 14, 2025 | marketbeat.comChromaDex Corp (OCD1.DU)June 11, 2025 | nz.finance.yahoo.comNiagen Bioscience to Participate in the BIO 2025 International ConventionJune 11, 2025 | businesswire.comNiagen Bioscience: High Conviction, High ExpectationsJune 11, 2025 | seekingalpha.comCanaccord Genuity Group Forecasts Strong Price Appreciation for Niagen Bioscience (NASDAQ:NAGE) StockJune 10, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Reaches New 1-Year High - Here's WhyJune 10, 2025 | marketbeat.comNiagen Bioscience Inc (NAGE) Announces Promising Clinical Study Results for Werner Syndrome ...June 9, 2025 | gurufocus.comNiagen Bioscience stock rises following positive clinical studyJune 9, 2025 | au.investing.comNiagen Bioscience Inc (NAGE) Announces Promising Clinical Study Results for Werner Syndrome ...June 9, 2025 | gurufocus.comNiagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic DisorderJune 9, 2025 | businesswire.comNiagen Bioscience (NASDAQ:NAGE) Cut to "Buy" at Wall Street ZenJune 6, 2025 | marketbeat.comWhat 4 Analyst Ratings Have To Say About Niagen BioscienceJune 6, 2025 | benzinga.comNiagen Bioscience (NASDAQ:NAGE) Price Target Raised to $23.00June 6, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Shares Gap Up - Time to Buy?June 6, 2025 | marketbeat.comNiagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce ConferenceJune 4, 2025 | finance.yahoo.comNiagen Bioscience to Present at Oppenheimer's 25th Annual Consumer Growth and E-Commerce ConferenceJune 4, 2025 | businesswire.comNiagen Bioscience (NASDAQ:NAGE) Sets New 12-Month High - Here's WhyJune 4, 2025 | marketbeat.comNAGE stock soars to 52-week high, hits $11.17 amid robust gainsJune 3, 2025 | investing.comNiagen Bioscience (NASDAQ:NAGE) Stock Price Up 8.2% - What's Next?June 3, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Reaches New 12-Month High - Still a Buy?May 30, 2025 | marketbeat.comNiagen Bioscience (NASDAQ:NAGE) Coverage Initiated by Analysts at Canaccord Genuity GroupMay 28, 2025 | marketbeat.comCanaccord Genuity Initiates Coverage of Niagen Bioscience (NAGE) with Buy RecommendationMay 28, 2025 | msn.comNAGE Niagen Bioscience, Inc.May 23, 2025 | seekingalpha.comNiagen Bioscience: Overbought After RallyMay 22, 2025 | seekingalpha.com Get Niagen Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for NAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address NAGE Media Mentions By Week NAGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAGE News Sentiment▼0.420.59▲Average Medical News Sentiment NAGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAGE Articles This Week▼73▲NAGE Articles Average Week Get Niagen Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for NAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACLX News Today MRUS News Today RNA News Today MTSR News Today AAPG News Today ACAD News Today SWTX News Today SRRK News Today VKTX News Today PTGX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAGE) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Niagen Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Niagen Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
